|
House Bill 3148 |
House Author: Parker et al. |
|
Effective: 9-1-19 |
Senate Sponsor: Bettencourt et al. |
House Bill 3148 amends the Health and Safety Code to set out provisions regarding the administration and oversight of investigational adult stem cell treatments administered to patients with certain severe chronic diseases or terminal illnesses, including provisions requiring the Department of State Health Services (DSHS) to administer the applicable statutory provisions, requiring DSHS to establish and maintain an investigational stem cell registry that lists each physician who administers an investigational stem cell treatment, and providing additional accreditation and registration options to fulfill a statutory requirement for an institutional review board that oversees investigational adult stem cell treatments.